Experience of targeted Usher exome sequencing as a clinical test - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Molecular Genetics & Genomic Medicine Année : 2014

Experience of targeted Usher exome sequencing as a clinical test


We show that massively parallel targeted sequencing of 19 genes provides a new and reliable strategy for molecular diagnosis of Usher syndrome (USH) and nonsyndromic deafness, particularly appropriate for these disorders characterized by a high clinical and genetic heterogeneity and a complex structure of several of the genes involved. A series of 71 patients including Usher patients previously screened by Sanger sequencing plus newly referred patients was studied. Ninety-eight percent of the variants previously identified by Sanger sequencing were found by next-generation sequencing (NGS). NGS proved to be efficient as it offers analysis of all relevant genes which is laborious to reach with Sanger sequencing. Among the 13 newly referred Usher patients, both mutations in the same gene were identified in 77% of cases (10 patients) and one candidate pathogenic variant in two additional patients. This work can be considered as pilot for implementing NGS for genetically heterogeneous diseases in clinical service.
Fichier principal
Vignette du fichier
Besnard_et_al-2014-Molecular_Genetics_&_Genomic_Medicine.pdf (927.19 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-02433835 , version 1 (27-01-2020)





Thomas Besnard, Gema García-García, David Baux, Christel Vaché, Valérie Faugère, et al.. Experience of targeted Usher exome sequencing as a clinical test. Molecular Genetics & Genomic Medicine, 2014, 2 (1), pp.30-43. ⟨10.1002/mgg3.25⟩. ⟨hal-02433835⟩
47 Consultations
173 Téléchargements



Gmail Facebook X LinkedIn More